Bayer AG

BAYRY-OTC

OTCMKTS:BAYRY

20.74
0.25 (1.19%)
Bayer AG; is a German multinational, pharmaceutical and life sciences company. It is headquartered in Leverkusen, where its illuminated sign is a landmark.
More at Wikipedia

Analysis and Opinions about BAYRY-OTC

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
December 7, 2018
Their last quarter wasn't great; there was some positive news in their pharma pipeline. They sold assets from BASF to reduce net debt, which is now at Euros 36.5 billion. The debt-to-cash flow is still high, so they have a low credit rating. Their chemical side isn't growing. EPS are down 18%, which pressured the stock. JNJ has a better phrama pipeline and credit rating.
Show full opinionHide full opinion
Bayer AG (BAYRY-OTC)
December 7, 2018
Their last quarter wasn't great; there was some positive news in their pharma pipeline. They sold assets from BASF to reduce net debt, which is now at Euros 36.5 billion. The debt-to-cash flow is still high, so they have a low credit rating. Their chemical side isn't growing. EPS are down 18%, which pressured the stock. JNJ has a better phrama pipeline and credit rating.
BUY WEAKNESS
BUY WEAKNESS
June 18, 2014

On these big Chemicals you are always best to wait for an opportunity to get in. There isn't an urgent rush. This company is a monstrously big company.

Show full opinionHide full opinion
Bayer AG (BAYRY-OTC)
June 18, 2014

On these big Chemicals you are always best to wait for an opportunity to get in. There isn't an urgent rush. This company is a monstrously big company.

DON'T BUY
DON'T BUY
July 25, 2005
Into pharmaceuticals and chemicals. Things seem to be moving along very well. Getting a little overpriced at these levels.
Show full opinionHide full opinion
Bayer AG (BAYRY-OTC)
July 25, 2005
Into pharmaceuticals and chemicals. Things seem to be moving along very well. Getting a little overpriced at these levels.
Showing 1 to 3 of 3 entries
  • «
  • 1
  • »